Sign In | Join Free | My
Search by Category
Home > Agrochemicals >

99% High Purity Axitinib Powder CAS: 319460-85-0 For Cancer Therapy

Categories Pharmaceutical Raw Materials
Brand Name: TINGYI
Model Number: 319460-85-0
Certification: GMP , ISO 9001:2008
Place of Origin: CHINA
MOQ: 1g
Price: Contact Us
Payment Terms: Bank Transfer - Bitcoin - Western Union - MoneyGram
Supply Ability: 5 KG/Month
Delivery Time: Within 7 Working Days
Packaging Details: Stealth And Discreet Packaging
Product Name: Axitinib
CAS: 319460-85-0
MF: C22H18N4OS
MW: 386.47
EINECS: 1308068-626-2
Appearance: Off-White Solid
Melting point: 213-215°C
  • Haven't found right suppliers
  • Our buyer assistants can help you find the most suitable, 100% reliable suppliers from China.
  • And this service is free of charge.
  • we have buyer assistants who speak English, French, Spanish......and we are ready to help you anytime!
  • Submit Buying Request
    • Product Details
    • Company Profile

    99% High Purity Axitinib Powder CAS: 319460-85-0 For Cancer Therapy

    Axitinib CAS: 319460-85-0

    Basic Details:

    Product Name: Axitinib
    Synonyms: Axitinib (usan);D03218;Axitinib(AG 013736);Axtinib;N-Methyl-2-({3-[(E)-2-

    (pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzaMide;Inlyta;10mg;Axitinib (TINIBS)
    CAS: 319460-85-0
    MF: C22H18N4OS
    MW: 386.47
    EINECS: 1308068-626-2

    Melting point 213-215°C
    density 1.4
    storage temp. -20°C Freezer
    solubility DMSO: ≥8mg/mL
    color white to tan

    Usage And Synthesis
    FDA approved axitinib use of treating advanced kidney cancer January 27, 2012, the FDA

    approved axitinib for the treatment of advanced kidney cancer (renal cell carcinoma) which

    other drugs unanswer . Inlyta is manufactured and sold by Pfizer,and is a oral pill taken

    twice a day.
    Renal cell carcinoma is a type of tumor originating from the tubular endothelial cells.

    Axitinib can prevent certain protein called kinases playing a role in tumor growth and

    metastasis .
    Axitinib is a small molecule tyrosine kinase inhibitor, effective against multiple targets,

    including VEGF receptors 1, 2 and 3.
    Dr. Richard Pazdur, hematology and oncology drugs office director of FDA Drug Evaluation

    and Research Centre, said: "This is the seven kind of drugs allowed treating metastatic or

    advanced renal cell carcinoma since 2005 . Overall, during this time ,record level of drug

    development has dramatically changed the treatment of metastatic renal cell carcinoma

    paradigm, and offers a variety of treatment options for patients. "
    In recent years, the drug has been approved for the treatment of kidney cancer include

    sorafenib (2005), sunitinib (2006), temsirolimus(2007), everolimus (2009), bevacizumab

    (2009) and pazopanib(2009).

    Chemical Properties Off-White Solid

    Uses A tyrosine kinase inhibitor; used in cancer therapy.
    Uses Axitinib (AG-013736) is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ

    and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM, respectively.
    Uses Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit

    with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM, respectively.
    Uses Axitinib is a tyrosine kinase inhibitor. Axitinib is used in cancer therapy.
    Definition ChEBI: An indazole substituted at position 3 by a 2-(pyridin-2-yl)vinyl

    group and at position 6 by a 2-(N-methylaminocarboxy)phenylsulfanyl group. Used for the

    treatment of advanced renal cell carcinoma after failure of a first line systemic tr


    1.Axitinib is also called by its brand name Inlyta. It is a type of drug called a tyrosine kinase inhibitor, which is a cancer growth blocker. It blocks certain proteins called tyrosine kinases from acting on cells. Tyrosine kinases signal to cancer cells to grow.Axitinib blocks different types of tyrosine kinase and is called a multi kinase inhibitor.
    It stops cancer cells forming blood vessels, which the cancer needs in order to grow. This is called anti angiogenesis treatment.Axitinib is a treatment for advanced kidney cancer. You may also have it as part of a clinical trial for other cancers including soft tissue sarcoma and thyroid cancer.

    2.Axitinib interferes with the growth of some cancer cells.Axitinib is used to treat advanced kidney cancer.Axitinib is usually given after other cancer medicine has been tried without success.

    Axitinib may also be used for purposes not listed in this medication guide.Axitinib dose-dependently inhibits tumor growth in MV522 with ED50 value of 8.8 mg/kg twice daily, based on the relationship between dose and the corresponding TGI (tumor growth inhibition).

    3.Axitinib is an oral tyrosine kinase inhibitor selective for vascular endothelial (VEGF) receptors -1, -2 and -3 that is used in the therapy of advanced renal cell carcinoma. Axitinib therapy is commonly associated with transient elevations in serum aminotransferase that are generally mild and asymptomatic. Axitinib has yet to be linked to instances of clinically apparent acute liver injury.

    Axitinib is indicated for kidney cancer. Axitinib is a kinase inhibitor shown to inhibit the vascular endothelial receptors (VEGFR-1, VEGFR-2, and VEGFR-3) implicated in angiogenesis and tumor growth leading to cancer progression.Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    Fast and safe delivery:

    1)Parcel can be sent out in 24 hours after payment. Tracking numbers available
    2)Secure and discreet shipment. Various transportation methods for your choice.
    3) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring.
    4)We have special way could ship 0.01kg to sveral kg products a time. We offer melting powder into liquid service. And ship the liquid in special bottles.
    5)Offer the latest tracking number for you to check

    Hot-Sale Pharmaceutical Raw Material












    Levamisole HCL










    Buy 99% High Purity Axitinib Powder CAS: 319460-85-0 For Cancer Therapy at wholesale prices
    Send your message to this supplier
    To: Chongqing Tingyi Biotechnology Co.,Ltd
    Characters Remaining: (0/3000)
    Inquiry Cart 0